User Guides & FAQs

What biotech M&A data does BPIQ offer?

Free:

• M&A Activity History
  

Pro:

• M&A Activity History

Elite:

What is a PDUFA Date?

A Prescription Drug User Fee Act (PDUFA) date is a pivotal milestone for pharmaceutical companies. It marks the FDA's expected completion date for reviewing New Drug Applications (NDAs) and Biologics License Applications (BLAs) submitted by companies seeking approval for new drugs. PDUFA dates are essential for planning marketing strategies, informing investors, and anticipating the potential approval of a new treatment.

Why are PDUFA Dates Important for Retail Investors?

PDUFA dates hold significant implications for retail investors interested in pharmaceutical stocks. These dates can trigger stock price fluctuations as anticipation and speculation build up around potential FDA approvals. Understanding PDUFA dates can help investors make informed decisions about buying, holding, or selling shares in pharmaceutical companies.

How are PDUFA Dates Determined?

PDUFA dates are determined by the FDA's review timeline and the type of drug being reviewed. Factors such as the drug's therapeutic area, unmet medical…

How can hedge fund data help biotech investors?

Hedge fund holdings can help you discover new investment ideas and get more conviction about your current holdings. For example, you can see how many top biotech or biopharma hedge funds hold your favorite companies or which tickers are the most popular tickers amongst top biotech or biopharma hedge funds. When you use hedge fund information, you leverage the expertise and resources of top hedge funds for your investment decisions. At BPIQ.com we provide information regarding holdings of top biopharma hedge funds. See FN2 below for the different hedge fund information available on BPIQ.com.

What data supports the value of top biopharma hedge fund data?

We conclude based on our monitoring and back-testing, that hedge fund data from top biopharma hedge funds can be very valuable in helping to make investment decisions. We find this especially true when we look across pools…

What is a Big-Mover™ event?

Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that are expected to move a stock by at least 20% up or down. Big Mover™ events are typically a type of event with the highest chance of moving a stock (e.g. Phase 2, Phase 3, and PDUFA read-outs) given the importance of the clinical asset to the sponsor company. We call clinical events that appear likely to be Big Mover events Suspected Big Mover events, until/unless stock options data for the sponsor company indicates that the stock is likely to move up or down by at least 20% within the relevant time period. 

The following Big/Suspected Mover Criteria outline further elaborates on this:

• Stage

• Indication

• MOA